| canada.com where perspectives connect
Since she was diagnosed with breast cancer in July 2004, Hetty Hazenberg has struggled for survival in two worlds - one of conventional medicine that focused on operations, chemotherapy and radiation, and the other of alternative medicine that considered her mind, spirit, and soul. More than three years later, the 38-year-old Dutch-born North Vancouver resident feels she has found the right balance, including a new job, a new outlook on life, and a foot in each medical camp. "I believe the two go hand in hand," says Hazenberg, who will undergo more testing next month. "I needed an operation, but there is so much we can do ourselves. We can't just focus on the body. We all have a mind, soul and spirit that needs to be healed, too." .
Zion Oktoberfest dinner
A special parish meeting will follow the service on Sunday, Oct. 28.The Harvest Dinner will be held on Friday, Nov. 2, with social hour at 6 p.m.The public is invited to a presentation at the church by author Beth Holloway at 7 p.m. Thursday, Nov. 8. Holloway will be speaking about her faith and hope. She suffered the kidnapping and disappearance of her daughter, Natalee, in Aruba, in the summer of 2005 during a class trip. Beth Holloway of Alabama has written a book titled "Loving Natalee."Call 547-6322 or visit www.christepiscopalchurch.net. The church is located one block west of Charlevoix's main downtown park at the corner of Clinton and State streets.Walloon Lake CommunityWALLOON LAKE — The Walloon Lake Community Church will host a prayer partner breakfast at 8 a.m. Saturday, Oct.
Panacea Pharmaceuticals Initiates GMP Manufacturing Of Prostate Cancer ...
Panacea Pharmaceuticals, Inc. has initiated manufacturing of PC Detect(SM) kits, the Company's diagnostic test for prostate cancer, under GMP conditions. Data on the performance of the PC Detect(SM) kit will be included in a Premarket Approval (PMA) application for this diagnostic test to be filed with the U.S. Food and Drug Administration in early 2008. To date, PC Detect(SM) has demonstrated sensitivity and specificity of greater than 90 percent in identifying men with prostate cancer. PC Detect(SM) was initially launched in May 2007 as a laboratory service by Panacea Laboratories, a division of Panacea Pharmaceuticals; Panacea Laboratories is regulated under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) to perform high-complexity testing. FDA approval of a PC Detect(SM) kit will facilitate the wider distribution and availability of this diagnostic test through clinical laboratories and hospitals across the U.S.
Treviso 33 Newport Gwent Dragons 35
Sweeney missed the chance to steady the ship when his penalty drifted wide and Treviso capitalised when Alberto Sgarbi beat Mustoe with ease to score a third try for Treviso. Goosen added the conversion as well as two long-range penalties to put the home side 33-32 ahead 15 minutes from time. But Newport switched back on and Sweeney's late drop-goal was enough to secure all five points. Click here to send us your sporting feedback .
Prostate cancer deadlier for overweight men: study
Obese men diagnosed with prostate cancer are nearly twice as likely as healthy-weight men to die from the disease, new research shows. The heavier a man is at the time of diagnosis the greater his risk of death, according to a study published in today's issue of the journal, Cancer. After five years, the death rate for normal weight men from locally advanced prostate cancer was 6.5 per cent, compared to 13 per cent for overweight men and 12 per cent for obese men. .
Benign lesions the same in dogs and humans
WEST LAFAYETTE, Ind., Nov. 26 (UPI) -- A team of U.S. and Italian scientists have found premalignant mammary lesions in dogs and humans display many of the same characteristics. The Purdue University-led researchers said their discovery could lead to better understanding of breast cancer progression and prevention for both people and their dogs. The scientists found similarities between benign lesions that are at risk for developing into breast cancer in both canines and humans, said Purdue veterinary scientist Sulma Mohammed, an associate professor of comparative pathobiology.. "Dogs develop these lesions spontaneously in contrast to other available models and are exposed to the same environmental risk factors as humans," said Mohammed. "These shared features make the dog an ideal model to compare the breast lesions that will progress to cancer and those that will regress.
|
